These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 30299027)

  • 21. [Clinical analysis and follow-up of neonatal purulent meningitis caused by group B streptococcus].
    Zhu M; Zhu J; Li H; Liu P; Lin Z
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):133-6. PubMed ID: 24739726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An autopsy case with lower motor neuron disease showing a transient-appearance of anti-GM1 antibody and an improvement of conduction block after gamma-globulin administration].
    Kikuchi H; Kawano Y; Dohura K; Kawamura T; Taniwaki T; Yamada T; Kato M; Iwaki T; Kira J
    No To Shinkei; 1999 May; 51(5):455-64. PubMed ID: 10396755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum antibodies to gangliosides in Guillain-Barré syndrome.
    Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
    Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Roodbol J; Hoogenboezem T; Jacobs E; van Rijn M; van der Eijk AA; Vink C; de Wit MC; van Rossum AM; Jacobs BC
    Ann Neurol; 2016 Oct; 80(4):566-80. PubMed ID: 27490360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute multifocal motor neuropathy with early spontaneous recovery: a distinct syndrome from Guillain-Barré syndrome?
    Wöhrle JC; Amoiridis G; Heye N; Przuntek H
    Electromyogr Clin Neurophysiol; 1996; 36(1):37-41. PubMed ID: 8654320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without Anti-GT1a IgG antibody.
    Arai M; Susuki K; Koga M
    Muscle Nerve; 2003 Aug; 28(2):246-50. PubMed ID: 12872333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome.
    Guzey Aras Y; Tanik O; Dogan Güngen B; Kotan D
    Ideggyogy Sz; 2016 Nov; 69(11-12):389-395. PubMed ID: 29733556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
    Mitsui Y; Kusunoki S; Arimura K; Kaji R; Kanda T; Kuwabara S; Sonoo M; Takada K;
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):110-4. PubMed ID: 24273220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
    Araki T; Nakata H; Kusunoki S; Arai Y; Katayama Y
    Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early enteral and parenteral nutrition on immune functions of neurocritically ill patients.
    Qi SY; Wang WT; Chen CY; Chu ZD; Liu XJ; Liu XJ
    J Biol Regul Homeost Agents; 2016; 30(1):227-32. PubMed ID: 27049096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of nerve stimulation at Erb point in early diagnosis of Guillain-Barré syndrome in children].
    Sun RD; Fu B; Li C; Kuang GT; Luo XQ; Jiang J
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jul; 17(7):683-6. PubMed ID: 26182271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-BarrÉ syndrome subtype diagnosis: A prospective multicentric European study.
    Van den Bergh PYK; Piéret F; Woodard JL; Attarian S; Grapperon AM; Nicolas G; Brisset M; Cassereau J; Rajabally YA; Van Parijs V; Verougstraete D; Jacquerye P; Raymackers JM; Redant C; Michel C; Delmont E;
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29315669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody].
    Ichikawa H; Susuki K; Yuki N; Kawamura M
    Rinsho Shinkeigaku; 2001 Aug; 41(8):523-5. PubMed ID: 11889840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.